Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study - Aronson, R; Frias, J; Goldman, A (Diabetes Obes Metab, 2018)
et al.